{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:33:02Z","timestamp":1767339182624},"reference-count":21,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rare cases of somatic mosaicism resulting from reversion of inherited mutations can lead to the attenuation of blood-cell disorders, including Wiskott-Aldrich syndrome (WAS). The impact of the revertant hematopoietic stem or progenitor cells, particularly their representation in blood-cell populations, is of interest because it predicts the outcome of gene therapy. Here we report an 8-year-old patient with WAS caused by a single nucleotide insertion in the WASP gene that abrogates protein expression. The patient nonetheless had mild disease. We found reversion of the mutation in a fraction of patient lymphocytes. Forty percent of natural killer (NK) cells expressed Wiskott-Aldrich syndrome protein (WASP), and NK cells contained both mutated and revertant (normal) sequences. WASP was not expressed in patient T or B cells; T cells contained only the mutated sequence. The selective advantage of WASP+ NK cells was also demonstrated for carrier females. The enrichment of WASP+-revertant NK cells indicates that WASP provides a selective advantage in this lineage and predicts the success of gene therapy for reconstituting the NK-cell compartment. The importance of reconstituting the NK-cell lineage is discussed. (Blood. 2005;106:2815-2817)<\/jats:p>","DOI":"10.1182\/blood-2004-12-4724","type":"journal-article","created":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T16:37:39Z","timestamp":1120063059000},"page":"2815-2817","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":32,"title":["Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome"],"prefix":"10.1182","volume":"106","author":[{"given":"Maxim I.","family":"Lutskiy","sequence":"first","affiliation":[{"name":"From the CBR Institute for Biomedical Research and the Department of Pediatrics, Harvard Medical School, Boston, MA; and the Department of Pediatrics, Yale University School of Medicine, New Haven, CT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana S.","family":"Beardsley","sequence":"additional","affiliation":[{"name":"From the CBR Institute for Biomedical Research and the Department of Pediatrics, Harvard Medical School, Boston, MA; and the Department of Pediatrics, Yale University School of Medicine, New Haven, CT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred S.","family":"Rosen","sequence":"additional","affiliation":[{"name":"From the CBR Institute for Biomedical Research and the Department of Pediatrics, Harvard Medical School, Boston, MA; and the Department of Pediatrics, Yale University School of Medicine, New Haven, CT."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Remold-O'Donnell","sequence":"additional","affiliation":[{"name":"From the CBR Institute for Biomedical Research and the Department of Pediatrics, Harvard Medical School, Boston, MA; and the Department of Pediatrics, Yale University School of Medicine, New Haven, CT."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021215293602900_REF1","doi-asserted-by":"crossref","unstructured":"Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASp-mediated haematological and immunological disease. Blood.2004;104: 3454-3462.","DOI":"10.1182\/blood-2004-04-1678"},{"key":"2020021215293602900_REF2","doi-asserted-by":"crossref","unstructured":"Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hot spots, effect on transcription and translation and phenotype\/genotype correlation. Blood.2004;104: 4010-4019.","DOI":"10.1182\/blood-2003-05-1592"},{"key":"2020021215293602900_REF3","doi-asserted-by":"crossref","unstructured":"Ariga T, Yamada M, Sakiyama Y, Tatsuzawa O. A case of Wiskott-Aldrich syndrome with dual mutations in exon 10 of the WASP gene: an additional de novo one-base insertion, which restores frame shift due to an inherent one-base deletion, detected in the major population of the patient's peripheral blood lymphocytes. Blood.1998;92: 699-701.","DOI":"10.1182\/blood.V92.2.699"},{"key":"2020021215293602900_","doi-asserted-by":"crossref","unstructured":"Ariga T, Kondoh T, Yamaguchi K, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol.2001;166: 5245-5249.","DOI":"10.4049\/jimmunol.166.8.5245"},{"key":"2020021215293602900_REF5","doi-asserted-by":"crossref","unstructured":"Wada T, Schurman SH, Otsu M, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A.2001;98: 8697-8702.","DOI":"10.1073\/pnas.151260498"},{"key":"2020021215293602900_REF6","doi-asserted-by":"crossref","unstructured":"Kenney DM. Wiskott-Aldrich syndrome and related X-linked thrombocytopenia. Curr Opin Pediatr.1990;2: 932-935.","DOI":"10.1097\/00008480-199010000-00014"},{"key":"2020021215293602900_REF7","doi-asserted-by":"crossref","unstructured":"Jones LN, Lutskiy MI, Cooley J, Kenney DM, Rosen FS, Remold-O'Donnell E. A novel protocol to identify mutations in patients with Wiskott-Aldrich syndrome. Blood Cells Mol Dis.2002;28: 392-398.","DOI":"10.1006\/bcmd.2002.0523"},{"key":"2020021215293602900_REF8","doi-asserted-by":"crossref","unstructured":"Remold-O'Donnell E, Cooley J, Shcherbina A, et al. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J Immunol.1997;158: 4021-4025.","DOI":"10.4049\/jimmunol.158.9.4021"},{"key":"2020021215293602900_REF9","doi-asserted-by":"crossref","unstructured":"Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood.1995;85: 2471-2477.","DOI":"10.1182\/blood.V85.9.2471.bloodjournal8592471"},{"key":"2020021215293602900_REF10","doi-asserted-by":"crossref","unstructured":"Ferlazzo G, Munz C. NK cell compartments and their activation by dendritic cells. J Immunol.2004;172: 1333-1339.","DOI":"10.4049\/jimmunol.172.3.1333"},{"key":"2020021215293602900_REF11","doi-asserted-by":"crossref","unstructured":"Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood.2001;97: 3146-3151.","DOI":"10.1182\/blood.V97.10.3146"},{"key":"2020021215293602900_","doi-asserted-by":"crossref","unstructured":"Fehniger TA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood.2003;101: 3052-3057.","DOI":"10.1182\/blood-2002-09-2876"},{"key":"2020021215293602900_REF13","doi-asserted-by":"crossref","unstructured":"Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol.2004;172: 1455-1462.","DOI":"10.4049\/jimmunol.172.3.1455"},{"key":"2020021215293602900_REF14","doi-asserted-by":"crossref","unstructured":"Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med.1999;5: 405-411.","DOI":"10.1038\/7403"},{"key":"2020021215293602900_","doi-asserted-by":"crossref","unstructured":"Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med.2002;195: 327-333.","DOI":"10.1084\/jem.20010938"},{"key":"2020021215293602900_","doi-asserted-by":"crossref","unstructured":"Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med.2002;195: 335-341.","DOI":"10.1084\/jem.20010934"},{"key":"2020021215293602900_REF17","doi-asserted-by":"crossref","unstructured":"Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol.2003;4: 175-181.","DOI":"10.1038\/ni880"},{"key":"2020021215293602900_REF18","doi-asserted-by":"crossref","unstructured":"Borg C, Jalil A, Laderach D, et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood.2004;104: 3267-3275.","DOI":"10.1182\/blood-2004-01-0380"},{"key":"2020021215293602900_REF19","doi-asserted-by":"crossref","unstructured":"Orange JS, Ramesh N, Remold-O'Donnell E, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A.2002;99: 11351-11356.","DOI":"10.1073\/pnas.162376099"},{"key":"2020021215293602900_REF20","doi-asserted-by":"crossref","unstructured":"Gismondi A, Cifaldi L, Mazza C, et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood.2004;104: 436-443.","DOI":"10.1182\/blood-2003-07-2621"},{"key":"2020021215293602900_REF21","doi-asserted-by":"crossref","unstructured":"Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2\/L3\/S2. Blood.2001;98: 705-713.","DOI":"10.1182\/blood.V98.3.705"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/8\/2815\/1635603\/zh802005002815.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/8\/2815\/1635603\/zh802005002815.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T16:15:08Z","timestamp":1683130508000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/8\/2815\/21814\/Mosaicism-of-NK-cells-in-a-patient-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,15]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-12-4724","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,15]]}}}